18-36122170-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_012319.4(SLC39A6):c.1241A>G(p.Glu414Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000929 in 1,613,988 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_012319.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC39A6 | ENST00000269187.10 | c.1241A>G | p.Glu414Gly | missense_variant | Exon 5 of 10 | 2 | NM_012319.4 | ENSP00000269187.4 | ||
SLC39A6 | ENST00000440549.6 | c.416A>G | p.Glu139Gly | missense_variant | Exon 4 of 8 | 1 | ENSP00000401139.1 | |||
SLC39A6 | ENST00000590986.5 | c.1241A>G | p.Glu414Gly | missense_variant | Exon 5 of 10 | 5 | ENSP00000465915.1 | |||
SLC39A6 | ENST00000586829.1 | c.-59A>G | upstream_gene_variant | 3 | ENSP00000467724.1 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152218Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 249496Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135360
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461770Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 727204
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152218Hom.: 0 Cov.: 33 AF XY: 0.0000672 AC XY: 5AN XY: 74370
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1241A>G (p.E414G) alteration is located in exon 5 (coding exon 4) of the SLC39A6 gene. This alteration results from a A to G substitution at nucleotide position 1241, causing the glutamic acid (E) at amino acid position 414 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at